Korean J Anesthesiol.
1998 Apr;34(4):852-856. 10.4097/kjae.1998.34.4.852.
The Effectiveness of Transdermal Fentanyl Patch in Cancer Pain Patients
- Affiliations
-
- 1Department of Anesthesiology, College of Medicine, Dankook University, Cheon an, Korea.
- 2Department of Anesthesiology, College of Medicine, Seoul National University, Seoul, Korea.
- KMID: 2039896
- DOI: http://doi.org/10.4097/kjae.1998.34.4.852
Abstract
-
BACKGROUND: The aim of this study was to investigate the suitability of a dose conversion table from oral morphine to transdermal fentanyl patch (TDFP) and to evaluate the efficacy and safety of TDFP in the treatment of cancer pain.
METHODS
Sixty cancer patients whose pain had been stabilized with oral morphine for at least 48 hours (morphine phase) were switched to TDFP using standard conversion chart for fentanyl dosage. TDFP were replaced every 72 hours for 9 days (fentanyl phase). Assessment of pain, nausea, vomiting, pruritus and somnolence were recorded as visual analogue scale (VAS).
RESULTS
Patients' pain assessment and side effects were not significantly different during both phases. But ten patients reported some skin reactions to the patch, such as erythema, itching, and papules.
CONCLUSIONS
TDFP were well tolerated and provided pain relief in cancer patients equivalent to that achieved with oral morphine.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Successful Treatment with High Dose Transdermal Fentanyl Patch for Severe Cancer Pain in a Patient with Lung Cancer
- Comparison of an Additional Transdermal Fentanyl Patch Compared to Intravenous NSAID and Opioid Analgesics within 24 Hours of an Uterine Artery Embolization for Myoma and Adenomyosis
- Two Cases of Fentanyl Intoxication Through Overusing Fentanyl Patch
- The Effect of Fentanyl Patch in the Treatment of Intractable Postherpetic Neuralgia
- A Case of Fentanyl Toxicity with Misused Durogesic Transdermal Patch
